Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
OcuSciences logo — OcuSciences has developed ocular imagers to detect and monit...

OcuSciences

OcuSciences has developed ocular imagers to detect and monitor eye disease by assessing retinal metabolic activity

Founded 2008 United States Ann Arbor, United States 7 employees Seed Total: $900.00K Biotechnology, Health Care +1

General Information

Company Name OcuSciences
Founded Year 2008
Location United States Ann Arbor, United States
Employees 7
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with OcuSciences. To contact OcuSciences, visit ocusciences.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About OcuSciences

OcuSciences, a biotechnology and healthcare startup based in the United States, was founded in 2008. The company has developed ocular imagers aimed at detecting and monitoring eye disease by assessing retinal metabolic activity. OcuSciences focuses on producing a rapid and non-invasive ocular imager, positioning itself at the intersection of technology and healthcare innovation. The startup received a $900.00K investment in a Seed Round on 01 May 2009, with the funding coming from Ann Arbor Spark. OcuSciences' dedication to addressing critical medical needs through cutting-edge technology makes it a compelling investment opportunity for venture capitalists seeking to support groundbreaking solutions in the healthcare sector.

Taxonomy: Ophthalmology, Medical diagnostics, Ocular imaging, Retinal metabolic dysfunction, Flavoprotein fluorescence, Ocular imager, Diabetes, AMD, Glaucoma, Health technology, Eye disease detection

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $900.00K 1
Ann Arbor Spark
Ann Arbor Spark
01 May 2009

OcuSciences Alternatives & Competitors

OcuSciences vs
Optovue
Optovue

Pioneering the future of ocular diagnostics with next-generation imaging technologies to enhance eye...

Private Equity
Health Care, Medical Devices
OcuSciences vs
iCare
iCare Finland

Establishing the next level of eye care.

Venture round
474 employees
Biotechnology, Health Care
OcuSciences vs
Clearside Biomedical, Inc.
Clearside Biomedical, Inc.

Revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (S...

Post-IPO Equity
39 employees
Biotechnology, Health Care

FAQ About OcuSciences

OcuSciences has developed ocular imagers to detect and monitor eye disease by assessing retinal metabolic activity
OcuSciences was founded in 2008.
OcuSciences is headquartered in Ann Arbor, United States.
OcuSciences operates in Biotechnology, Health Care and Medical Devices. Its work centres on Ophthalmology, Medical diagnostics, Ocular imaging and Retinal metabolic dysfunction.
OcuSciences has approximately 7 employees.
OcuSciences has completed 1 funding round, raising a total of $900.00K. The latest funding stage is Seed.
Top alternatives and competitors to OcuSciences include Optovue, iCare, Clearside Biomedical, Inc., Inoveon Corporation, Oivi. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
OcuSciences and Optovue are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for OcuSciences, https://bouncewatch.com/company/ocusciences, updated 5 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes